Discount Contract for Golimumab
Original notice title
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026-21 - Golimumab
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No estimated value or volume information, making it difficult to assess potential business impact.
As an Open House discount contract, there is no guaranteed revenue; uptake depends on pharmacy substitution.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Jul 2027
- Supply of pharmaceutical products containing the active substance Golimumab
- Conclusion of discount contracts under § 130a Abs. 8 SGB V with standardized terms and conditions
Show full summary
Open House discount contract (Rabattvertrag) for the active substance Golimumab, administered by Techniker Krankenkasse (TK) on behalf of multiple German health insurance funds. Contract conclusion occurs under § 130a Abs. 8 SGB V with standardized terms, no exclusive rights, and a maximum duration of 12 months starting 01.08.2026, extendable by 12 months. This is an Open House procedure, not a public procurement subject to competition rules. No estimated value is provided.
Risks
No estimated value or volume information, making it difficult to assess potential business impact.
As an Open House discount contract, there is no guaranteed revenue; uptake depends on pharmacy substitution.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Pharmaceutical entrepreneur status (as per § 4 Abs. 18 AMG) for the offered medicinal product
- Valid marketing authorization or entitlement to market the product under own name
- Place of business in the AMG area, EU, or EEA
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Discount Contract for Golimumab
Discount contract for the active substance Golimumab under an Open House procedure. Contract concluded with all eligible pharmaceutical entrepreneurs who meet the qualification requirements.
Location
Duration
Category
Award Criteria
Deadline
Award details
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Golimumab zu schließen.
Value note
Show original TED data
Original lot title
Open House Biologika Rabattverträge 2026-21 - Golimumab
Original TED description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Golimumab zu schließen.
Procurement Details
- Publication date
- 07 Jun 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 389754-2026
Documents (1)
Similar tenders
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Romania – Street-cleaning and sweeping services – Acord cadru de prestare a serviciilor de delegare a activităților de măturat, spălat, stropit si întreținerea căilor publice și activități de curățare și transport al zăpezii de pe căile publice și menținerea în funcțiune a acestora pe timp de polei sau îngheț, pe timp de iarnă din cadrul serviciului de salubrizare a orașului Negrești Oaș
France – Insurance services – MARCHE DE SERVICES EN ASSURANCE
Spain – Building-cleaning services – Servicios de limpieza en Centros de Sevilla, Murcia y Galicia, de la Agencia Estatal Consejo Superior de Investigaciones Científicas.
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No estimated value or volume information, making it difficult to assess potential business impact.
As an Open House discount contract, there is no guaranteed revenue; uptake depends on pharmacy substitution.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications